ea0011p677 | Reproduction | ECE2006
Lane HA
, Smith jC
, Morris K
, Cockcroft J
, Goodfellow J
, Scanlon MF
, Davies JS
Backround: Male hypogonadism is associated with an increased incidence of cardiovascular risk factors and approximately 25% of males suffering with coronary heart disease are hypogonadal. Few studies have assessed the impact of testosterone therapy on vascular function in hypogonadal individuals and none have investigated the weekly impact of gradually reducing testosterone concentrations on vasculature.Patients and Methods: 10 hypogonadal subjects (6 wi...